Shopify Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? Shopify Inc. trades at $168.98 (market cap $227.12B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Shopify Inc. is far larger — about 126.2× Vir Biotechnology Inc. Common Stock's market cap, and Shopify Inc. is trading nearer its 52-week high, Vir Biotechnology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Shopify Inc. for 78 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SHOP | VIR | |
|---|---|---|
Market Cap | $227.12B | $1.80B |
Volume | 6,965,160 | 1,782,836 |
Sector | Technology | Health |
52-Week High | $179.22 | $11.78 |
52-Week Low | $95.40 | $5.12 |
Typical Hold Time | 78 Days | 0 Days |
Enterprise Value | $222.35B | $1.36B |
Signals from Pluang's Aura AI — not financial advice
SHOP trades at $172.50, down 3.75% today but maintains a bullish technical outlook with strong moving average support. The company shows robust revenue growth from $5.6B in 2022 to $11.6B in 2025, though valuation ratios remain elevated with a P/E of 119.27. Recent news highlights Shopify's AI innovations including Canvas site-building tool and open AI agent checkout, positioning it favorably against competitors.
Shopify's outlook remains positive with 67% analyst buy ratings and $172.47 consensus target. Key opportunities include AI-driven commerce expansion and merchant solutions growth accelerating to 37%. Risks include high valuation multiples and competitive pressure from Amazon's opposing AI strategy. The stock offers growth potential but requires monitoring of earnings sustainability.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →